Skin extensibility and consistency in patients with Ehlers-Danlos syndrome and benign joint hypermobility syndrome
- PMID: 19169910
- DOI: 10.1080/03009740802520714
Skin extensibility and consistency in patients with Ehlers-Danlos syndrome and benign joint hypermobility syndrome
Abstract
Objectives: The reproducibility of clinical tests for skin extensibility and consistency, essential for differentiating between types of Ehlers-Danlos syndrome (EDS) and benign joint hypermobility syndrome (BJHS), is unknown. Paraclinical methods may provide objective differential diagnostic methods.
Methods: Six EDS, 11 BJHS, and 19 controls completed the trial. We analysed the overall inter-examiner agreement on clinical tests for skin extensibility and consistency, in addition to analyses on suction cup (SC) and soft tissue stiffness meter (STSM) methods.
Results: Overall agreement on tests for skin extensibility and consistency varied between 0.44 and 0.72. Extensibility evaluated by SC showed an insignificant difference between EDS patients and controls (p = 0.056). Consistency evaluated by STSM showed significant differences (p = 0.001).
Conclusions: Overall inter-examiner agreement on clinical tests for skin extensibility and consistency was below 0.80, which was required a priori to conduct a reproducibility study. Further refinement of tests and a training phase are necessary. The SC and STSM results are encouraging but must be reproduced in a larger study population.
Similar articles
-
Skin signs in Ehlers-Danlos syndrome: clinical tests and para-clinical methods.Scand J Rheumatol. 2010 Nov;39(6):511-7. doi: 10.3109/03009741003781977. Epub 2010 Aug 5. Scand J Rheumatol. 2010. PMID: 20684735 Clinical Trial.
-
Assessment of skin extensibility and joint hypermobility in patients with spontaneous cervical artery dissection and Ehlers-Danlos syndrome.J Clin Neurosci. 2008 Jun;15(6):650-3. doi: 10.1016/j.jocn.2007.08.001. Epub 2008 Apr 8. J Clin Neurosci. 2008. PMID: 18400501
-
A novel in vivo skin extensibility test for joint hypermobility.J Rheumatol. 2010 Jul;37(7):1513-8. doi: 10.3899/jrheum.091192. Epub 2010 Jun 15. J Rheumatol. 2010. PMID: 20551108
-
The clinical presentation of Ehlers-Danlos syndrome.Adv Neonatal Care. 2005 Dec;5(6):301-14. doi: 10.1016/j.adnc.2005.09.006. Adv Neonatal Care. 2005. PMID: 16338669 Review.
-
[Ehlers-Danlos syndrome, with special emphasis in the joint hypermobility syndrome].Rev Med Chil. 2009 Nov;137(11):1488-97. Epub 2010 Jan 13. Rev Med Chil. 2009. PMID: 20098810 Review. Spanish.
Cited by
-
Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.Orphanet J Rare Dis. 2020 Jul 31;15(1):197. doi: 10.1186/s13023-020-01470-0. Orphanet J Rare Dis. 2020. PMID: 32736638 Free PMC article.
-
Chronic pain in hypermobility syndrome and Ehlers-Danlos syndrome (hypermobility type): it is a challenge.J Pain Res. 2015 Aug 20;8:591-601. doi: 10.2147/JPR.S64251. eCollection 2015. J Pain Res. 2015. PMID: 26316810 Free PMC article. Review.
-
Quantitative measures of tissue mechanics to detect hypermobile Ehlers-Danlos syndrome and hypermobility syndrome disorders: a systematic review.Clin Rheumatol. 2020 Mar;39(3):715-725. doi: 10.1007/s10067-020-04939-2. Epub 2020 Jan 18. Clin Rheumatol. 2020. PMID: 31955324
-
Mechanobiology in the Comorbidities of Ehlers Danlos Syndrome.Front Cell Dev Biol. 2022 Apr 25;10:874840. doi: 10.3389/fcell.2022.874840. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35547807 Free PMC article. Review.
-
Biomarkers for Ehlers-Danlos Syndromes: There Is a Role?Int J Mol Sci. 2021 Sep 20;22(18):10149. doi: 10.3390/ijms221810149. Int J Mol Sci. 2021. PMID: 34576312 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
